Skip to content
Screener

Atara Biotherapeutics ATRA Q1 2026 earnings

Reported May 12, 2026 · Before market open

Revenue$516.0KMiss by $2.4M
EPS-$0.29Beat by $0.04
Revenue estimate$2.9M
EPS estimate-$0.33

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$800.0K
EPS estimate-$0.13

FAQ

When did Atara Biotherapeutics report Q1 2026 earnings?
Atara Biotherapeutics (ATRA) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Atara Biotherapeutics's Q1 2026 revenue and EPS?
Atara Biotherapeutics reported revenue of $516.0K and eps of $-0.29 for Q1 2026.
Did Atara Biotherapeutics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $2.9M by $2.4M. EPS beat the consensus estimate of $-0.33 by $0.04.
How did Atara Biotherapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 99.5% from $98.1M a year earlier.
Where can I find Atara Biotherapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-219420) and the 10-Q periodic report (0001193125-26-219482) directly on SEC EDGAR. The filing index links above go to sec.gov.